Insider Trading History of Brady Todd C

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Brady Todd C since 2014. This trader's CIK number is 1579179. At the time of last reporting, Brady Todd C was the President and CEO of Aldeyra Therapeutics, Inc.. (stock ticker symbol ALDX). Also see all insider trading activities at Aldeyra Therapeutics, Inc..

Note that in the past Brady Todd C also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Outlook Therapeutics, Inc. (ONS) by Brady Todd C

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 ONS 0 $0 0 $0 28,985 $0

Yearly summary of insider trading at Evoke Pharma Inc (EVOK) by Brady Todd C

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 EVOK 4,000 $22,800 0 $0 0 $0

Yearly summary of insider trading at Aldeyra Therapeutics, Inc. (ALDX) by Brady Todd C

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 ALDX 0 $0 183,238 $580,808 0 $0
2023 ALDX 0 $0 0 $0 273,058 $150,728
2022 ALDX 17,700 $59,542 0 $0 0 $0
2019 ALDX 84,678 $465,101 0 $0 0 $0
2017 ALDX 22,223 $100,003 0 $0 0 $0
2014 ALDX 12,500 $100,000 0 $0 0 $0


Insider trading activities at 3 companies by Brady Todd C:

1. Outlook Therapeutics, Inc. (ONS)

2. Evoke Pharma Inc (EVOK)

3. Aldeyra Therapeutics, Inc. (ALDX)

Table 1. Insider trading of Outlook Therapeutics, Inc. (ONS) by Brady Todd C

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-11-09 ONS Option Ex 28,985 .00 0

Table 2. Insider trading of Evoke Pharma Inc (EVOK) by Brady Todd C

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-09-23 EVOK Buy 4,000 5.70 22,800

Table 3. Insider trading of Aldeyra Therapeutics, Inc. (ALDX) by Brady Todd C

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-03-11 ALDX Sale 97,914 3.27 320,570
2024-03-12 ALDX Sale 85,324 3.05 260,238
2023-09-07 ALDX Option Ex 273,058 .55 150,728
2022-06-23 ALDX Buy 17,700 3.36 59,542
2019-12-16 ALDX Buy 20,000 5.09 101,900
2019-09-30 ALDX Buy 8,710 5.68 49,481
2019-09-23 ALDX Buy 8,680 5.81 50,430
2019-09-18 ALDX Buy 14,288 5.91 84,470
2019-09-13 ALDX Buy 10,000 5.79 57,900
2019-09-16 ALDX Buy 3,000 6.03 18,090
2019-09-09 ALDX Buy 10,000 4.89 48,890
2019-09-10 ALDX Buy 10,000 5.39 53,940
2017-02-17 ALDX Buy 22,223 4.50 100,003
2014-05-07 ALDX Buy 12,500 8.00 100,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brady Todd C (President and CEO of Aldeyra Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.